newsfilter
← Latest News
GlobeNewswire·

EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma

Expands Pipeline Beyond Ophthalmology with PP-001, a Clinical Stage, Best-in-Class DHODH Inhibitor PP-001 Leverages a Validated Immune Modulating Mechanism Optimized for Increased Specificity and...